medecolМедицина и экологияMedicine and ecology2305-60452305-6053Карагандинский медицинский университетmedecol-325Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEКогнитивные нарушения у пациентов, перенесших COVID-19Cognitive impairments of patients who had a COVID-19СейтбаеваМ. А.SeitbayevaM. A.

Макпал Амиржановна Сейтбаева – м.м.н., преподаватель школы сестриснкого образования, тел.: +77476682511

Караганда

School of Nursing Education

Karaganda

Seytbaeva@qmu.kzКиспаеваТ. Т.KispayevaT. T.

Школа сестринского образования

Караганда

School of Nursing Education

Karaganda

ЖунусоваС. У.ZhunusovaS. U.

Школа сестринского образования

Караганда

School of Nursing Education

Karaganda

КалбековЖ. А.KalbekovZh. A.

Школа сестринского образования

Караганда

School of Nursing Education

Karaganda

БольшаковаИ. А.BolshakovaI. A.

Школа сестринского образования

Караганда

School of Nursing Education

Karaganda

Медицинский университет КарагандыКазахстанKaraganda Medical UniversityKazakhstan202228052023031215Copyright © Сейтбаева М.А., Киспаева Т.Т., Жунусова С.У., Калбеков Ж.А., Большакова И.А., 20232023Сейтбаева М.А., Киспаева Т.Т., Жунусова С.У., Калбеков Ж.А., Большакова И.А.Seitbayeva M.A., Kispayeva T.T., Zhunusova S.U., Kalbekov Z.A., Bolshakova I.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medecol.qmu.kz/jour/article/view/325

В статье изучались нарушения когнитивных функций, возникающие у пациентов после COVID – 19. Согласно данным обзора, после COVID – 19 у пациентов значительно снизились память, внимание, мышление, и было обнаружено, что это состояние встречается в 1/3 случаев у пациентов. Исследование показало, что наряду с медикаментозной и немедикаментозной терапией, то есть симптоматическим лечением после COVID – 19, в этом случае очень эффективно предлагать пациентам когнитивную реабилитацию.

The article studied cognitive impairments that occur in patients after COVID – 19. According to the review, after COVID – 19, memory, attention, and thinking significantly decreased in patients, and it was found that this condition occurs in 1/3 of cases in patients. The study showed that along with drug and non–drug therapy, that is, symptomatic treatment after COVID - 19, in this case it is very effective to offer cognitive rehabilitation to patients.

COVID-19когнитивные нарушенияневрологичесике нарушениякогнитивная реабилитацияCOVID-19cognitive disordersneurological disorderscognitive rehabilitationReferencesAlemanno F., Houdayer E., Parma A., et al. COVID-19 Cognitive Deficits after Respiratory Assistance in the Subacute Phase: A COVIDRehabilitation Unit Experience. // PLoS One. - 2021. - №16(2). – Р. 36 - 41. doi: 10.1371/journal.pone.0246590.Alemanno F., Houdayer E., Parma A., et al. COVID-19 Cognitive Deficits after Respiratory Assistance in the Subacute Phase: A COVIDRehabilitation Unit Experience. // PLoS One. - 2021. - №16(2). – Р. 36 - 41. doi: 10.1371/journal.pone.0246590.Arbi YM, Harthi A, Hussein J. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERSCoV). // Infection. – 2015.- № 43(4). – Р.495-501. doi: 10.1007/s15010-015-0720-y.Arbi YM, Harthi A, Hussein J. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERSCoV). // Infection. – 2015.- № 43(4). – Р.495-501. doi: 10.1007/s15010-015-0720-y.Batty, G. D., Deary, I. J., Luciano, M., et al. Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. // Brain Behav. Immun. – 2020. - №5(2). – Р.56 – 68. doi: 10.1016/j.bbi.2020.06.021Batty, G. D., Deary, I. J., Luciano, M., et al. Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. // Brain Behav. Immun. – 2020. - №5(2). – Р.56 – 68. doi: 10.1016/j.bbi.2020.06.021Bridwell R., Long B., Gottlieb M. Neurologic Complications of COVID-19. // Am J Emerg Med. – 2020. - № 38(7). – Р. 365- 375. doi: 10.1016/j.ajem.2020.05.024.Bridwell R., Long B., Gottlieb M. Neurologic Complications of COVID-19. // Am J Emerg Med. – 2020. - № 38(7). – Р. 365- 375. doi: 10.1016/j.ajem.2020.05.024.Carfì A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. // JAMA. - 2020. - № 324(6). – Р. 603–605. doi: 10.1001/jama.2020.12603.Carfì A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. // JAMA. - 2020. - № 324(6). – Р. 603–605. doi: 10.1001/jama.2020.12603.Contini C., Mariachiara DN., Nicole B., et al. The novel zoonotic COVID-19 pandemic: An expected global health concern // J Infect Dev Ctries. – 2020. - №14(3). – P. 254-264. doi: 10.3855/jidc.12671Contini C., Mariachiara DN., Nicole B., et al. The novel zoonotic COVID-19 pandemic: An expected global health concern // J Infect Dev Ctries. – 2020. - №14(3). – P. 254-264. doi: 10.3855/jidc.12671Dong L., Bouey J. Public mental health crisis during COVID-19 pandemic,China // Emerg Infect Dis. – 2020. - №26. – P. 1616-1618.Dong L., Bouey J. Public mental health crisis during COVID-19 pandemic,China // Emerg Infect Dis. – 2020. - №26. – P. 1616-1618.Ellul M.A., Benjamin L., Singh B., et al. Neurological Associations of COVID-19. // Lancet Neurol. – 2020. - № 19(9). – Р. 767– 783. doi: 10.1016/S1474-4422(20)30221-0.Ellul M.A., Benjamin L., Singh B., et al. Neurological Associations of COVID-19. // Lancet Neurol. – 2020. - № 19(9). – Р. 767– 783. doi: 10.1016/S1474-4422(20)30221-0.Galougahi M, Ghorbani J, Bakhshayeshkaram M, Safavi Naeini A, Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV‑2-induced anosmia: the first report.//Academic Radiology. – 2020. – № 25(6). – Р. 587 – 596. doi:10.1016/j.acra.2020.04.002Galougahi M, Ghorbani J, Bakhshayeshkaram M, Safavi Naeini A, Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV‑2-induced anosmia: the first report.//Academic Radiology. – 2020. – № 25(6). – Р. 587 – 596. doi:10.1016/j.acra.2020.04.002Goertz Y.M.J., Van Herck M., Delbressine J.M., et al. Persistent Symptoms 3 Months after a SARS-CoV-2 Infection: the Post-COVID- 19 Syndrome? //ERJ Open Res .- 2020. - № 6(4). – Р. 345 - 358. doi: 10.1183/23120541.00542-2020.Goertz Y.M.J., Van Herck M., Delbressine J.M., et al. Persistent Symptoms 3 Months after a SARS-CoV-2 Infection: the Post-COVID- 19 Syndrome? //ERJ Open Res .- 2020. - № 6(4). – Р. 345 - 358. doi: 10.1183/23120541.00542-2020.Hampshire A, Trender W, Chamberlain SR, et al. Cognitive deficits in people who have recovered from COVID-19 relative to controls.//medRxiv. – 2020. – № 18(9). – Р. 260 – 275. doi: 10.1101/2020.10.20.20215863Hampshire A, Trender W, Chamberlain SR, et al. Cognitive deficits in people who have recovered from COVID-19 relative to controls.//medRxiv. – 2020. – № 18(9). – Р. 260 – 275. doi: 10.1101/2020.10.20.20215863Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. // JAMA. – 2010. - № 304(16). – Р. 1787- 94. doi: 10.1001/jama.2010.1553Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. // JAMA. – 2010. - № 304(16). – Р. 1787- 94. doi: 10.1001/jama.2010.1553Jaywant A., Vanderlind W.M., Alexopoulos G.S., et al.. Frequency and Profile of Objective Cognitive Deficits in Hospitalized Patients Recovering from COVID-19.// Neuropsychopharmacology. - 2021. - №32(6). – Р. 1–6. doi: 10.1038/s41386-021-00978-8.Jaywant A., Vanderlind W.M., Alexopoulos G.S., et al.. Frequency and Profile of Objective Cognitive Deficits in Hospitalized Patients Recovering from COVID-19.// Neuropsychopharmacology. - 2021. - №32(6). – Р. 1–6. doi: 10.1038/s41386-021-00978-8.Liu K., Pan M., Xiao Z., et al. Neurological Manifestations of the Coronavirus (SARS-CoV-2) Pandemic 2019–2020. // J Neurol Neurosurg Psychiatry. – 2020. - № 91(6). – Р. 669–670. doi: 10.1136/jnnp-2020-323177.Liu K., Pan M., Xiao Z., et al. Neurological Manifestations of the Coronavirus (SARS-CoV-2) Pandemic 2019–2020. // J Neurol Neurosurg Psychiatry. – 2020. - № 91(6). – Р. 669–670. doi: 10.1136/jnnp-2020-323177.McLoughlin, B. C., Miles, A., Webb, T. E., et al. Functional and cognitive outcomes after COVID-19 delirium.// Eur. Geriatr. Med. – 2020. – № 11(9). – Р. 54-68. doi: 10.1007/s41999-020-00353-8.McLoughlin, B. C., Miles, A., Webb, T. E., et al. Functional and cognitive outcomes after COVID-19 delirium.// Eur. Geriatr. Med. – 2020. – № 11(9). – Р. 54-68. doi: 10.1007/s41999-020-00353-8.Pandharipande P. P. Long-term cognitive impairment after critical illness. // N. Engl. J. Med. – 2018. – № 36(9). – Р. 1306–1316.Pandharipande P. P. Long-term cognitive impairment after critical illness. // N. Engl. J. Med. – 2018. – № 36(9). – Р. 1306–1316.Pinna, P., Grewal, P., Hall, J. P., et al. Neurological manifestations and COVID-19: experiences from a tertiary care center at the Frontline. //J. Neurol. Sci. – 2020. – 36(12). – Р. 28 – 36. doi: 10.1016/j.jns.2020.116969Pinna, P., Grewal, P., Hall, J. P., et al. Neurological manifestations and COVID-19: experiences from a tertiary care center at the Frontline. //J. Neurol. Sci. – 2020. – 36(12). – Р. 28 – 36. doi: 10.1016/j.jns.2020.116969Shishir Paudel , Ganesh Dangal , Anisha Chalise , et.al. The Coronavirus Pandemic: What Does the Evidence Show? // J Nepal Health Res Counс. – 2020. - №18(1). – P. 1-9. doi: 10.33314/jnhrc.v18i1.2596Shishir Paudel , Ganesh Dangal , Anisha Chalise , et.al. The Coronavirus Pandemic: What Does the Evidence Show? // J Nepal Health Res Counс. – 2020. - №18(1). – P. 1-9. doi: 10.33314/jnhrc.v18i1.2596Simpson R, Robinson L. Rehabilitation after critical illness in people with COVID-19 infection. // Am J Phys Med Rehabil. – 2020. – № 99(3). – Р. 470–474. doi:10.1097/PHM.0000000000001443Simpson R, Robinson L. Rehabilitation after critical illness in people with COVID-19 infection. // Am J Phys Med Rehabil. – 2020. – № 99(3). – Р. 470–474. doi:10.1097/PHM.0000000000001443Troyer E.A., Kohn J.N., Hong S. Are We Facing a Crashing Wave of Neuropsychiatric Sequelae of COVID-19? Neuropsychiatric Symptoms and potential Immunologic Mechanisms. //Brain Behav Immun. – 2020. - № 87. – Р. 34–39. doi: 10.1016/j.bbi.2020.04.027.Troyer E.A., Kohn J.N., Hong S. Are We Facing a Crashing Wave of Neuropsychiatric Sequelae of COVID-19? Neuropsychiatric Symptoms and potential Immunologic Mechanisms. //Brain Behav Immun. – 2020. - № 87. – Р. 34–39. doi: 10.1016/j.bbi.2020.04.027.Varatharaj, A., Thomas, N., Ellul, M. A., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. // Lancet Psychiatry. – 2020. - №7(1). – Р. 875–882. doi: 10.1016/S2215-0366(20)30287-XVaratharaj, A., Thomas, N., Ellul, M. A., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. // Lancet Psychiatry. – 2020. - №7(1). – Р. 875–882. doi: 10.1016/S2215-0366(20)30287-XWilcox M.E., Brummel N.E., Archer K., et al. Cognitive Dysfunction in ICU Patients: Risk Factors, Predictors, and Rehabilitation Interventions. // Crit Care Med. – 2018. – № 41(9). – Р. 81–98. doi: 10.1097/CCM.0b013e3182a16946.Wilcox M.E., Brummel N.E., Archer K., et al. Cognitive Dysfunction in ICU Patients: Risk Factors, Predictors, and Rehabilitation Interventions. // Crit Care Med. – 2018. – № 41(9). – Р. 81–98. doi: 10.1097/CCM.0b013e3182a16946.Zhou H, Lu S, Chen J, et al. The landscape of cognitive function in recovered COVID-19 patients. // J Psychiatr Res. – 2020. - № 129. – Р. 98-102. doi: 10.1016/j.jpsychires.2020.06.022.Zhou H, Lu S, Chen J, et al. The landscape of cognitive function in recovered COVID-19 patients. // J Psychiatr Res. – 2020. - № 129. – Р. 98-102. doi: 10.1016/j.jpsychires.2020.06.022.

The authors declare that there are no conflicts of interest present.